Showing results (161-170 of 243) with videos related to
Sort By:
Pageof 25
Gastroenterology|September 9, 2008
Identification of CD4 T-cell epitopes in soluble liver antigen/liver pancreas autoantigen in autoimmune hepatitisHeiko Mix, Christina Weiler-Normann, Robert Thimme, et al.Journal of Virology|February 8, 2013
The frequency of CD127(+) hepatitis C virus (HCV)-specific T cells but not the expression of exhaustion markers predicts the outcome of acute HCV infectionEui-Cheol Shin, Su-Hyung Park, Michelina Nascimbeni, et al.Expert Opinion on Drug Safety|May 31, 2024
Immune checkpoint inhibitors and neurotoxicity: a focus on diagnosis and management for a multidisciplinary approachDesirèe Speranza, Mariacarmela Santarpia, Francesco Luppino, et al.Human Cell|August 29, 2020
BL1391: an established cell line from a human malignant peripheral nerve sheath tumor with unique genomic featuresDoron Tolomeo, Antonio Agostini, Gemma Macchia, et al.Plos One|December 14, 2023
Deciphering the immune landscape of head and neck squamous cell carcinoma: A single-cell transcriptomic analysis of regulatory T cell responses to PD-1 blockade therapyAdib Miraki Feriz, Fatemeh Bahraini, Arezou Khosrojerdi, et al.Biomedicines|September 28, 2021
Anti-COVID-19 Vaccination in Patients with Autoimmune-Autoinflammatory Disorders and Primary/Secondary Immunodeficiencies: The Position of the Task Force on Behalf of the Italian Immunological SocietiesRaffaele D'Amelio, Riccardo Asero, Marco Antonio Cassatella, et al.Endocrine, Metabolic & Immune Disorders Drug Targets|January 20, 2024
Predicting Factors of Worse Prognosis in COVID-19: Results from a Cross-sectional Study on 52 Inpatients Admitted to the Internal Medicine DepartmentGiuseppe Lisco, Antonio Giovanni Solimando, Assunta Stragapede, et al.Journal of Immunology (Baltimore, Md. : 1950)|September 10, 2002
Impaired effector function of hepatitis C virus-specific CD8+ T cells in chronic hepatitis C virus infectionHeiner Wedemeyer, Xiao-Song He, Michelina Nascimbeni, et al.Hepatology (Baltimore, Md.)|September 8, 2011
Early changes in interferon signaling define natural killer cell response and refractoriness to interferon-based therapy of hepatitis C patientsBirgit Edlich, Golo Ahlenstiel, Aintzane Zabaleta Azpiroz, et al.Virology|May 12, 2007
High levels of subgenomic HCV plasma RNA in immunosilent infectionsFlavien Bernardin, Susan L Stramer, Barbara Rehermann, et al.Pageof 25